The point prevalence of patients with diagnosed HF in their patient record at baseline was 15.4% but, according to BNP levels, the prevalence might have been closer to 50% if further examinations had been conducted in subjects with BNP values above the suggested cut-off for HF. This evidence concerns the gene NPPB and hydrops fetalis.